🔎 Trials Near Me

Home › Multiple Myeloma › Ohio › Akron

Multiple Myeloma clinical trials in Akron, OH

5 studies for Multiple Myeloma are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 3
  • Gabrail Cancer Center, Canton · 21 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07518186

Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)

RecruitingPhase 1/2
  • Gabrail Cancer & Research Center, Canton · 21 mi away
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06087653

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

RecruitingPhase 1/2
  • GSK Investigational Site, Canton · 21 mi away
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05714839

Integrated Cancer Repository for Cancer Research

RecruitingObservational studyHealthy volunteers welcome
  • Aultman Hospital, Canton · 21 mi away
  • Aultman Alliance Community Hospital, Alliance · 24 mi away
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

RecruitingObservational study
  • Tri-County Hematology & Oncology Associates, Inc., Massillon · 20 mi away
  • Cleveland Clinic Mercy Hospital, Canton · 21 mi away
Ages 18 and older · All sexes · Updated Feb 23, 2026 · NCT05974150

About Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.

More about Multiple Myeloma on MedlinePlus

Multiple Myeloma trials in other cities

Other studies in Akron

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.